Our California countdown is at T-5 days. Recently, I took a look at the new JAMA study, Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes – The SURPASS-5 Randomized Clinical Trial, and I have some thoughts. First, the management of type 2 diabetesContinue reading “Tirzepatide “
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Philip A. Lederer 